Mast cells as critical effectors of host immune defense against gram-negative bacteria

Current Medicinal Chemistry

Volumn 19, Issue 10, 2012, Pages 1432-1442

  Matsuguchi, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Ceramide; Chemokine; Cytokine; Eicosanoid; Gram negative bacteria; LPS; Reactive oxygen species; Toll like receptor

Indexed keywords

BACTERIAL ANTIGEN; BETA INTERFERON; CD48 ANTIGEN; CERAMIDE; CHEMOKINE; COMPLEMENT RECEPTOR; CYTOKINE; FC RECEPTOR; FUMONISIN; HISTAMINE; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; OPSONIN; PEPTIDOGLYCAN; PHOSPHOLIPASE A; PROTEINASE; SPHINGOLIPID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; BACTERICIDAL ACTIVITY; BACTERIUM DETECTION; CELL PHAGOCYTOSIS; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; EFFECTOR CELL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

CELL DEGRANULATION; CYTOKINES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MAST CELLS; OPSONIN PROTEINS; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84858766200     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799828319     Document Type: Review

References (147)

1. Metcalfe, D.D.; Baram, D.; Mekori, Y.A. Mast cells. Physiol. Rev., 1997, 77, 1033-1079. (Pubitemid 27459579)
2. Abraham, S.N.; St John, A.L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol., 2010, 10, (6), 440-452.
3. Malaviya, R.; Ikeda, T.; Ross, E.; Abraham, S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-?. Nature, 1996, 381, 77.
4. Echtenacher, B.; Mannel, D.N.; Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature, 1996, 381, 75.
5. Nakano, T.; Waki, N.; Asai, H.; Kitamura, Y. Different repopulation profile between erythroid and nonerythroid progenitor cells in genetically anemic W/Wv mice after bone marrow transplantation. Blood, 1989, 74, 1552-1556. (Pubitemid 19251528)
6. Puddington, L.; Olson, S.; Lefrancois, L. Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. Immunity, 1994, 1, 733-739.
7. Gern, J.E. Viral and bacterial infections in the development and progression of asthma. J. Allergy Clin. Immunol., 2000, 105, S497-502. (Pubitemid 30109015)
8. Yamashita, M.; Nakayama, T. Progress in allergy signal research on mast cells: regulation of allergic airway inflammation through toll-like receptor 4-mediated modification of mast cell function. J Pharmacol. Sci., 2008, 106, 332-335. (Pubitemid 351468583)
9. Galli, S.J.; Kalesnikoff, J.; Grimbaldeston, M.A.; Piliponsky, A.M.; Williams, C.M.; Tsai, M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 2005, 23, 749-786. (Pubitemid 40563184)
10. Abraham, S.N.; Malaviya, R. Mast cells in infection and immunity. Infect. Immun., 1997, 65, 3501-3508. (Pubitemid 27398100)
11. Okayama, Y.; Kirshenbaum, A.S.; Metcalfe, D.D. Expression of a functional high-affinity IgG receptor, Fc?RI, on human mast cells: Up-regulation by IFN-?. J. Immunol., 2000, 164, 4332-4339. (Pubitemid 30215096)
12. Garriga, M.M.; Friedman, M.M.; Metcalfe, D.D. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J. Allergy Clin. Immunol., 1988, 82, 425-432.
13. Xiang, Z.; Block, M.; Lofman, C.; Nilsson, G. IgE-mediated mast cell degranulation and recovery monitored by time-lapse photography. J. Allergy Clin. Immunol., 2001, 108, 116-121. (Pubitemid 32662241)
14. Welle, M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol., 1997, 61, 233-245. (Pubitemid 27149902)
15. Ghildyal, N.; McNeil, H.P.; Gurish, M.F.; Austen, K.F.; Stevens, R.L. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J. Biol. Chem., 1992, 267, 8473-8477.
16. Toru, H.; Eguchi, M.; Matsumoto, R.; Yanagida, M.; Yata, J.; Nakahata, T. Interleukin-4 promotes the development of tryptase and chymase doublepositive human mast cells accompanied by cell maturation. Blood, 1998, 91, 187-195. (Pubitemid 28018744)
17. Oskeritzian, C.A.; Zhao, W.; Min, H.K.; Xia, H.Z.; Pozez, A.; Kiev, J.; Schwartz, L.B. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J. Allergy Clin. Immunol., 2005, 115, 1162-1168. (Pubitemid 40824584)
18. Genovese, A.; Bouvet, J.P.; Florio, G.; Lamparter-Schummert, B.; Bjorck, L.; Marone, G. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect. Immun., 2000, 68, 5517-5524.
19. Ruan, M.R.; Akkoyunlu, M.; Grubb, A.; Forsgren, A. Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J. Immunol., 1990, 145, 3379-3384.
20. Jendholm, J.; Morgelin, M.; Perez Vidakovics, M.L.; Carlsson, M.; Leffler, H.; Cardell, L.O.; Riesbeck, K. Superantigen-and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis. J. Immunol., 2009, 182, 4713-4720.
21. Fureder, W.; Agis, H.; Willheim, M.; Bankl, H.C.; Maier, U.; Kishi, K.; Muller, M.R.; Czerwenka, K.; Radaszkiewicz, T.; Butterfield, J.H.; Klappacher, G.W.; Sperr, W.R.; Oppermann, M.; Lechner, K.; Valent, P. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol., 1995, 155, 3152-3160.
22. Marshall, J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol., 2004, 4, 787-799. (Pubitemid 39336295)
23. Gaither, T.A.; Vargas, I.; Inada, S.; Frank, M.M. The complement fragment C3d facilitates phagocytosis by monocytes. Immunology, 1987, 62, 405-411.
24. Michishita, M.; Videm, V.; Arnaout, M.A. A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell, 1993, 72, 857-867. (Pubitemid 23110228)
25. Sher, A.; Hein, A.; Moser, G.; Caulfield, J.P. Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab. Invest., 1979, 41, 490-499. (Pubitemid 10168515)
26. Rosenkranz, A.R.; Coxon, A.; Maurer, M.; Gurish, M.F.; Austen, K.F.; Friend, D.S.; Galli, S.J.; Mayadas, T.N. Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J. Immunol., 1998, 161, 6463-6467. (Pubitemid 28562181)
27. Nilsson, G.; Johnell, M.; Hammer, C.H.; Tiffany, H.L.; Nilsson, K.; Metcalfe, D.D.; Siegbahn, A.; Murphy, P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxinsensitive signal transduction pathway. J. Immunol., 1996, 157, 1693-1698. (Pubitemid 126449112)
28. Malaviya, R.; Gao, Z.; Thankavel, K.; van der Merwe, P.A.; Abraham, S.N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl. Acad. Sci. USA, 1999, 96, 8110-8115. (Pubitemid 29328416)
29. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell, 2006, 124, 783-801. (Pubitemid 43261452)
30. Jin, M.S.; Kim, S.E.; Heo, J.Y.; Lee, M.E.; Kim, H.M.; Paik, S.G.; Lee, H.; Lee, J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell, 2007, 130, 1071-1082. (Pubitemid 47410281)
31. Kang, J.Y.; Nan, X.; Jin, M.S.; Youn, S.J.; Ryu, Y.H.; Mah, S.; Han, S.H.; Lee, H.; Paik, S.G.; Lee, J.O. Recognition of lipopeptide patterns by Tolllike receptor 2-Toll-like receptor 6 heterodimer. Immunity, 2009, 31, 873-884.
32. Supajatura, V.; Ushio, H.; Nakao, A.; Okumura, K.; Ra, C.; Ogawa, H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol., 2001, 167, 2250-2256. (Pubitemid 32747537)
33. Park, B.S.; Song, D.H.; Kim, H.M.; Choi, B.S.; Lee, H.; Lee, J.O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 2009, 458, 1191-1195.
34. Ulevitch, R.J.; Tobias, P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 1995, 13, 437-457.
35. Medvedev, A.E.; Blanco, J.C.; Qureshi, N.; Vogel, S.N. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release. J. Biol. Chem., 1999, 274, 9342-9350.
36. Pan, Z.; Zhou, L.; Hetherington, C.J.; Zhang, D.E. Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes. J. Biol. Chem., 2000, 275, 36430-36435.
37. Huber, M.; Kalis, C.; Keck, S.; Jiang, Z.; Georgel, P.; Du, X.; Shamel, L.; Sovath, S.; Mudd, S.; Beutler, B.; Galanos, C.; Freudenberg, M.A. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells. Eur. J. Immunol., 2006, 36, 701-711.
38. Chen, G.; Shaw, M.H.; Kim, Y.G.; Nunez, G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol., 2009, 4, 365-398.
39. Chamaillard, M.; Hashimoto, M.; Horie, Y.; Masumoto, J.; Qiu, S.; Saab, L.; Ogura, Y.; Kawasaki, A.; Fukase, K.; Kusumoto, S.; Valvano, M.A.; Foster, S.J.; Mak, T.W.; Nunez, G.; Inohara, N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol., 2003, 4, 702-707. (Pubitemid 36874448)
40. Inohara, N.; Ogura, Y.; Fontalba, A.; Gutierrez, O.; Pons, F.; Crespo, J.; Fukase, K.; Inamura, S.; Kusumoto, S.; Hashimoto, M.; Foster, S.J.; Moran, A.P.; Fernandez-Luna, J.L.; Nunez, G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem., 2003, 278, 5509-5512. (Pubitemid 36800790)
41. Feng, B.S.; He, S.H.; Zheng, P.Y.; Wu, L.; Yang, P.C. Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am. J. Pathol., 2007, 171, 537-547. (Pubitemid 47344686)
42. Okumura, S.; Yuki, K.; Kobayashi, R.; Okamura, S.; Ohmori, K.; Saito, H.; Ra, C.; Okayama, Y. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cellrecruiting molecules via NOD2 in mast cells. Clin. Immunol., 2009, 130, 175-185.
43. Kalesnikoff, J.; Galli, S.J. New developments in mast cell biology. Nat. Immunol., 2008, 9, 1215-1223.
44. Swindle, E.J.; Metcalfe, D.D.; Coleman, J.W. Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J. Biol. Chem., 2004, 279, 48751-48759. (Pubitemid 39625752)
45. Heneberg, P.; Draberova, L.; Bambouskova, M.; Pompach, P.; Draber, P. Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts. J. Biol. Chem., 2010, 285, 12787-12802.
46. Ali, H. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol. Lett., 2010, 128, 36-45.
47. Supajatura, V.; Ushio, H.; Nakao, A.; Akira, S.; Okumura, K.; Ra, C.; Ogawa, H. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest., 2002, 109, 1351-1359. (Pubitemid 34546900)
48. Varadaradjalou, S.; Feger, F.; Thieblemont, N.; Hamouda, N.B.; Pleau, J.M.; Dy, M.; Arock, M. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol., 2003, 33, 899-906. (Pubitemid 36546677)
49. McCurdy, J.D.; Olynych, T.J.; Maher, L.H.; Marshall, J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol., 2003, 170, 1625-1629. (Pubitemid 36197374)
50. Ikeda, T.; Funaba, M. Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol. Lett., 2003, 88, 21-26. (Pubitemid 36835844)
51. Haidl, I.D.; McAlpine, S.M.; Marshall, J.S. Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation. Int. Arch. Allergy Immunol., 2011, 154, 227-235.
52. Tancowny, B.P.; Karpov, V.; Schleimer, R.P.; Kulka, M. Substance P primes lipoteichoic acid-and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2. Immunology, 2010, 131, 220-230.
53. Larsen, G.L.; Henson, P.M. Mediators of inflammation. Annu. Rev. Immunol., 1983, 1, 335-359.
54. Bradley, J.R. TNF-mediated inflammatory disease. J. Pathol., 2008, 214, 149-160. (Pubitemid 351160153)
55. Ferrante, A. Activation of neutrophils by interleukins-1 and-2 and tumor necrosis factors. Immunol. Ser., 1992, 57, 417-436.
56. Gordon, J.R.; Galli, S.J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med., 1991, 174, 103-107.
57. Hueber, A.J.; Asquith, D.L.; Miller, A.M.; Reilly, J.; Kerr, S.; Leipe, J.; Melendez, A.J.; McInnes, I.B. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol., 2010, 184, 3336-3340.
58. Lin, A.M.; Rubin, C.J.; Khandpur, R.; Wang, J.Y.; Riblett, M.; Yalavarthi, S.; Villanueva, E.C.; Shah, P.; Kaplan, M.J.; Bruce, A.T. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol., 2011, 187, 490-500.
59. Heneberg, P. Mast cells and basophils: trojan horses of conventional linstem/progenitor cell isolates. Curr.Pharm.Des., 2011, 17, 3753-3771.
60. Yao, Z.; Painter, S.L.; Fanslow, W.C.; Ulrich, D.; Macduff, B.M.; Spriggs, M.K.; Armitage, R.J. Human IL-17: a novel cytokine derived from T cells. J. Immunol., 1995, 155, 5483-5486.
61. Liang, S.C.; Tan, X.Y.; Luxenberg, D.P.; Karim, R.; Dunussi-Joannopoulos, K.; Collins, M.; Fouser, L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med., 2006, 203, 2271-2279. (Pubitemid 44498362)
62. Peric, M.; Koglin, S.; Kim, S.M.; Morizane, S.; Besch, R.; Prinz, J.C.; Ruzicka, T.; Gallo, R.L.; Schauber, J. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol., 2008, 181, 8504-8512.
63. Balamayooran, T.; Batra, S.; Balamayooran, G.; Cai, S.; Kobayashi, K.S.; Flavell, R.A.; Jeyaseelan, S. Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A. Infect. Immun., 2011, 79, 4588-4599.
64. Crowe, C.R.; Chen, K.; Pociask, D.A.; Alcorn, J.F.; Krivich, C.; Enelow, R.I.; Ross, T.M.; Witztum, J.L.; Kolls, J.K. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol., 2009, 183, 5301-5310.
65. Huang, C.; Friend, D.S.; Qiu, W.T.; Wong, G.W.; Morales, G.; Hunt, J.; Stevens, R.L. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol., 1998, 160, 1910-1919. (Pubitemid 28106480)
66. Huang, C.; De Sanctis, G.T.; O'Brien, P.J.; Mizgerd, J.P.; Friend, D.S.; Drazen, J.M.; Brass, L.F.; Stevens, R.L. Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung. J. Biol. Chem., 2001, 276, 26276-26284.
67. Tani, K.; Ogushi, F.; Kido, H.; Kawano, T.; Kunori, Y.; Kamimura, T.; Cui, P.; Sone, S. Chymase is a potent chemoattractant for human monocytes and neutrophils. J. Leukoc. Biol., 2000, 67, 585-589.
68. Molino, M.; Barnathan, E.S.; Numerof, R.; Clark, J.; Dreyer, M.; Cumashi, A.; Hoxie, J.A.; Schechter, N.; Woolkalis, M.; Brass, L.F. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem., 1997, 272, 4043-4049. (Pubitemid 27078466)
69. Dery, O.; Corvera, C.U.; Steinhoff, M.; Bunnett, N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol., 1998, 274, C1429-C1452.
70. Shpacovitch, V.M.; Varga, G.; Strey, A.; Gunzer, M.; Mooren, F.; Buddenkotte, J.; Vergnolle, N.; Sommerhoff, C.P.; Grabbe, S.; Gerke, V.; Homey, B.; Hollenberg, M.; Luger, T.A.; Steinhoff, M. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J. Leukoc. Biol., 2004, 76, 388-398. (Pubitemid 39006953)
71. D'Andrea, M.R.; Rogahn, C.J.; Andrade-Gordon, P. Localization of proteaseactivated receptors-1 and-2 in human mast cells: indications for an amplified mast cell degranulation cascade. Biotech. Histochem., 2000, 75, 85-90. (Pubitemid 30618405)
72. Boyce, J.A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev., 2007, 217, 168-185. (Pubitemid 46718145)
73. Hammarstrom, S. Leukotrienes. Annu. Rev. Biochem., 1983, 52, 355-377. (Pubitemid 13030687)
74. Malaviya, R.; Abraham, S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol., 2000, 67, 841-846.
75. Woolhiser, M.R.; Brockow, K.; Metcalfe, D.D. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. Clin. Immunol., 2004, 110, 172-180. (Pubitemid 38296707)
76. Benjamim, C.F.; Canetti, C.; Cunha, F.Q.; Kunkel, S.L.; Peters-Golden, M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J. Immunol., 2005, 174, 1616-1620.
77. Bailie, M.B.; Standiford, T.J.; Laichalk, L.L.; Coffey, M.J.; Strieter, R.; Peters-Golden, M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol., 1996, 157, 5221-5224. (Pubitemid 126448936)
78. Burd, P.R.; Rogers, H.W.; Gordon, J.R.; Martin, C.A.; Jayaraman, S.; Wilson, S.D.; Dvorak, A.M.; Galli, S.J.; Dorf, M.E. Interleukin 3-dependent and-independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med., 1989, 170, 245-257. (Pubitemid 19179708)
79. Burd, P.R.; Thompson, W.C.; Max, E.E.; Millis, F.C. Activated mast cells produce intreleukin 13. J. Exp. Med., 1995, 181, 1373.
80. Kawakami, T.; Galli, S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol., 2002, 2, 773-786. (Pubitemid 37328717)
81. Masuda, A.; Yoshikai, Y.; Aiba, K.; Matsuguchi, T. Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. J. Immunol., 2002, 169, 3801-3810.
82. Zhu, F.G.; Marshall, J.S. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells. J. Leukoc. Biol., 2001, 69, 253-262. (Pubitemid 32163438)
83. Enoksson, M.; Ejendal, K.F.; McAlpine, S.; Nilsson, G.; Lunderius-Andersson, C. Human cord blood-derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines. J. Innate Immun., 2011, 3, 142-149.
84. Kharazmi, A.; Nielsen, H.; Rechnitzer, C.; Bendtzen, K. Interleukin 6 primes human neutrophil and monocyte oxidative burst response. Immunol. Lett., 1989, 21, 177-184. (Pubitemid 19135912)
85. Sutherland, R.E.; Olsen, J.S.; McKinstry, A.; Villalta, S.A.; Wolters, P.J. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J. Immunol., 2008, 181, 5598-5605.
86. Punnonen, J.; Aversa, G.; Cocks, B.G.; McKenzie, A.N.; Menon, S.; Zurawski, G.; de Waal Malefyt, R.; de Vries, J.E. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA, 1993, 90, 3730-3734. (Pubitemid 23111441)
87. Sanderson, C.J. Interleukin-5, eosinophils, and disease. Blood, 1992, 79, 3101-3109.
88. Cao, F.; Castrillo, A.; Tontonoz, P.; Re, F.; Byrne, G.I. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Tolllike receptor 2. Infect. Immun., 2007, 75, 753-759. (Pubitemid 46203437)
89. Bulut, Y.; Shimada, K.; Wong, M.H.; Chen, S.; Gray, P.; Alsabeh, R.; Doherty, T.M.; Crother, T.R.; Arditi, M. Chlamydial heat shock protein 60 induces acute pulmonary inflammation in mice via the Toll-like receptor 4-and MyD88-dependent pathway. Infect. Immun., 2009, 77, 2683-2690.
90. Bisgaard, H.; Hermansen, M.N.; Buchvald, F.; Loland, L.; Halkjaer, L.B.; Bonnelykke, K.; Brasholt, M.; Heltberg, A.; Vissing, N.H.; Thorsen, S.V.; Stage, M.; Pipper, C.B. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med., 2007, 357, 1487-1495. (Pubitemid 47572634)
91. Arbour, N.C.; Lorenz, E.; Schutte, B.C.; Zabner, J.; Kline, J.N.; Jones, M.; Frees, K.; Watt, J.L.; Schwartz, D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet., 2000, 25, 187.
92. Strohmeier, G.R.; Walsh, J.H.; Klings, E.S.; Farber, H.W.; Cruikshank, W.W.; Center, D.M.; Fenton, M.J. Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma. J. Immunol., 2001, 166, 2063-2070. (Pubitemid 32114696)
93. Nakano, N.; Nishiyama, C.; Kanada, S.; Niwa, Y.; Shimokawa, N.; Ushio, H.; Nishiyama, M.; Okumura, K.; Ogawa, H. Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood, 2007, 109, 4846-4855. (Pubitemid 46827781)
94. Couper, K.N.; Blount, D.G.; Riley, E.M. IL-10: the master regulator of immunity to infection. J. Immunol., 2008, 180, 5771-5777.
95. Howard, M.; Muchamuel, T.; Andrade, S.; Menon, S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med., 1993, 177, 1205-1208. (Pubitemid 23097411)
96. Gerard, C.; Bruyns, C.; Marchant, A.; Abramowicz, D.; Vandenabeele, P.; Delvaux, A.; Fiers, W.; Goldman, M.; Velu, T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med., 1993, 177, 547-550. (Pubitemid 23117107)
97. Okumura, S.; Kashiwakura, J.; Tomita, H.; Matsumoto, K.; Nakajima, T.; Saito, H.; Okayama, Y. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood, 2003, 102, 2547-2554. (Pubitemid 37193594)
98. Lin, T.J.; Maher, L.H.; Gomi, K.; McCurdy, J.D.; Garduno, R.; Marshall, J.S. Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa. Infect. Immun., 2003, 71, 365-373. (Pubitemid 36026040)
99. Di Nardo, A.; Vitiello, A.; Gallo, R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol., 2003, 170, 2274-2278. (Pubitemid 36245611)
100. Zanetti, M.; Litteri, L.; Gennaro, R.; Horstmann, H.; Romeo, D. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J. Cell. Biol., 1990, 111, 1363-1371.
101. Agerberth, B.; Gunne, H.; Odeberg, J.; Kogner, P.; Boman, H.G.; Gudmundsson, G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA, 1995, 92, 195-199.
102. Gallo, R.L.; Kim, K.J.; Bernfield, M.; Kozak, C.A.; Zanetti, M.; Merluzzi, L.; Gennaro, R. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem., 1997, 272, 13088-13093. (Pubitemid 27216731)
103. Cruse, G.; Fernandes, V.E.; de Salort, J.; Pankhania, D.; Marinas, M.S.; Brewin, H.; Andrew, P.W.; Bradding, P.; Kadioglu, A. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin. J. Immunol., 2010, 184, 7108-7115.
104. Cirioni, O.; Giacometti, A.; Ghiselli, R.; Bergnach, C.; Orlando, F.; Silvestri, C.; Mocchegiani, F.; Licci, A.; Skerlavaj, B.; Rocchi, M.; Saba, V.; Zanetti, M.; Scalise, G. LL-37 protects rats against lethal sepsis caused by gramnegative bacteria. Antimicrob. Agents Chemother., 2006, 50, 1672-1679.
105. Padawer, J.; Fruhman, G.J. Phagocytosis of zymosan particles by mast cells. Experientia, 1968, 24, 471-472.
106. Otani, I.; Conrad, D.H.; Carlo, J.R.; Segal, D.M.; Ruddy, S. Phagocytosis by rat peritoneal mast cells: independence of IgG Fc-mediated and C3-mediated signals. J. Immunol., 1982, 129, 2109-2112. (Pubitemid 12004378)
107. Malaviya, R.; Ross, E.A.; MacGregor, J.I.; Ikeda, T.; Little, J.R.; Jakschik, B.A.; Abraham, S.N. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol., 1994, 152, 1907-1914. (Pubitemid 24075724)
108. Arock, M.; Ross, E.; Lai-Kuen, R.; Averlant, G.; Gao, Z.; Abraham, S.N. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect. Immun., 1998, 66, 6030-6034. (Pubitemid 28531872)
109. Henricks, P.A.; Nijkamp, F.P. Reactive oxygen species as mediators in asthma. Pulm. Pharmacol.Ther., 2001, 14, 409-420.
110. Malaviya, R.; Twesten, N.J.; Ross, E.A.; Abraham, S.N.; Pfeifer, J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol., 1996, 156, 1490-1496. (Pubitemid 26065860)
111. Poncet, P.; Arock, M.; David, B. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation. J. Leukoc. Biol., 1999, 66, 105-112. (Pubitemid 29321377)
112. Frandji, P.; Tkaczyk, C.; Oskeritzian, C.; David, B.; Desaymard, C.; Mecheri, S. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur. J. Immunol., 1996, 26, 2517-2528. (Pubitemid 26340958)
113. Gong, J.; Yang, N.S.; Croft, M.; Weng, I.C.; Sun, L.; Liu, F.T.; Chen, S.S. The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II. BMC Immunol., 2010, 11, 34.
114. Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D.S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil extracellular traps kill bacteria. Science, 2004, 303, 1532-1535. (Pubitemid 38314426)
115. Martinelli, S.; Urosevic, M.; Daryadel, A.; Oberholzer, P.A.; Baumann, C.; Fey, M.F.; Dummer, R.; Simon, H.U.; Yousefi, S. Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J. Biol. Chem., 2004, 279, 44123-44132. (Pubitemid 39390721)
116. von Kockritz-Blickwede, M.; Goldmann, O.; Thulin, P.; Heinemann, K.; Norrby-Teglund, A.; Rohde, M.; Medina, E. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood, 2008, 111, 3070-3080.
117. Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol., 2010, 11, 373-384.
118. Suzuki, N.; Suzuki, S.; Duncan, G.S.; Millar, D.G.; Wada, T.; Mirtsos, C.; Takada, H.; Wakeham, A.; Itie, A.; Li, S.; Penninger, J.M.; Wesche, H.; Ohashi, P.S.; Mak, T.W.; Yeh, W.C. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature, 2002, 416, 750-756.
119. Kobayashi, K.; Hernandez, L.D.; Galan, J.E.; Janeway, C.A., Jr.; Medzhitov, R.; Flavell, R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell, 2002, 110, 191-202. (Pubitemid 34876547)
120. Deng, L.; Wang, C.; Spencer, E.; Yang, L.; Braun, A.; You, J.; Slaughter, C.; Pickart, C.; Chen, Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell, 2000, 103, 351-361.
121. Ninomiya-Tsuji, J.; Kishimoto, K.; Hiyama, A.; Inoue, J.; Cao, Z.; Matsumoto, K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature, 1999, 398, 252-256.
122. Matsuguchi, T.; Masuda, A.; Sugimoto, K.; Nagai, Y.; Yoshikai, Y. JNKinteracting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation. EMBO J., 2003, 22, 4455-4464. (Pubitemid 37087199)
123. Davis, R.J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev., 1995, 42, 459-467.
124. Karin, M.; Liu, Z.; Zandi, E. AP-1 function and regulation. Curr. Opin. Cell. Biol., 1997, 9, 240-246. (Pubitemid 27135992)
125. Masuda, A.; Yoshikai, Y.; Kume, H.; Matsuguchi, T. The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J. Immunol., 2004, 173, 5564-5573. (Pubitemid 39392143)
126. Masuda, A.; Hashimoto, K.; Yokoi, T.; Doi, T.; Kodama, T.; Kume, H.; Ohno, K.; Matsuguchi, T. Essential role of GATA transcriptional factors in the activation of mast cells. J. Immunol., 2007, 178, 360-368. (Pubitemid 46033619)
127. Wang, C.; Deng, L.; Hong, M.; Akkaraju, G.R.; Inoue, J.; Chen, Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature, 2001, 412, 346-351. (Pubitemid 32694385)
128. Gon, Y.; Nunomura, S.; Ra, C. Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells. Clin. Exp. Allergy, 2005, 35, 635-642. (Pubitemid 40769289)
129. Aoki, M.; Akiyama, T.; Miyoshi, J.; Toyoshima, K. Identification and characterization of protein products of the cot oncogene with serine kinase activity. Oncogene, 1991, 6, 1515-1519. (Pubitemid 21924252)
130. Chiariello, M.; Marinissen, M.J.; Gutkind, J.S. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol. Cell. Biol., 2000, 20, 1747-1758. (Pubitemid 30100193)
131. Salmeron, A.; Ahmad, T.B.; Carlile, G.W.; Pappin, D.; Narsimhan, R.P.; Ley, S.C. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J., 1996, 15, 817-826.
132. Beinke, S.; Ley, S.C. Functions of NF-?B1 and NF-?B2 in immune cell biology. Biochem. J., 2004, 382, 393-409. (Pubitemid 39243905)
133. Dumitru, C.D.; Ceci, J.D.; Tsatsanis, C.; Kontoyiannis, D.; Stamatakis, K.; Lin, J.H.; Patriotis, C.; Jenkins, N.A.; Copeland, N.G.; Kollias, G.; Tsichlis, P.N. TNF-induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell, 2000, 103, 1071-1083. (Pubitemid 32040907)
134. Sugimoto, K.; Ohata, M.; Miyoshi, J.; Ishizaki, H.; Tsuboi, N.; Masuda, A.; Yoshikai, Y.; Takamoto, M.; Sugane, K.; Matsuo, S.; Shimada, Y.; Matsuguchi, T. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J. Clin. Invest., 2004, 114, 857-866. (Pubitemid 39578745)
135. Kakimoto, K.; Musikacharoen, T.; Chiba, N.; Bandow, K.; Ohnishi, T.; Matsuguchi, T. Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation. J. Physiol. Biochem., 2010, 66, 47-53.
136. Chiba, N.; Kakimoto, K.; Masuda, A.; Matsuguchi, T. Functional roles of Cot/Tpl2 in mast cell responses to lipopolysaccharide and FcepsilonRIclustering. Biochem. Biophys. Res. Commun., 2010, 402, 1-6.
137. Keck, S.; Muller, I.; Fejer, G.; Savic, I.; Tchaptchet, S.; Nielsen, P.J.; Galanos, C.; Huber, M.; Freudenberg, M.A. Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells. J. Immunol., 2011, 186, 5478-5488.
138. MacKichan, M.L.; DeFranco, A.L. Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog. J. Biol. Chem., 1999, 274, 1767-1775.
139. Hannun, Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 1994, 269, 3125-3128. (Pubitemid 24237615)
140. Spiegel, S.; Foster, D.; Kolesnick, R. Signal transduction through lipid second messengers. Curr. Opin. Cell. Biol., 1996, 8, 159-167. (Pubitemid 26109088)
141. Hannun, Y.A. Functions of ceramide in coordinating cellular responses to stress. Science, 1996, 274, 1855-1859. (Pubitemid 26424756)
142. Prieschl, E.E.; Csonga, R.; Novotny, V.; Kikuchi, G.E.; Baumruker, T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fcreceptor 1 triggering. J. Exp. Med., 1999, 190, 1-8. (Pubitemid 29330118)
143. Chiba, N.; Masuda, A.; Yoshikai, Y.; Matsuguchi, T. Ceramide inhibits LPSinduced production of IL-5, IL-10, and IL-13 from mast cells. J. Cell. Physiol., 2007, 213, 126-136. (Pubitemid 47378800)
144. McNeil, H.P.; Adachi, R.; Stevens, R.L. Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J. Biol. Chem., 2007, 282, 20785-20789. (Pubitemid 47099891)
145. Anonymus. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet, 1998, 351, 1225-1232.
146. Flohr, C.; Quinnell, R.J.; Britton, J. Do helminth parasites protect against atopy and allergic disease? Clin. Exp. Allergy, 2009, 39, 20-32.
147. Cao, Q.P.; Li, J.F.; Zhang, P.N.; Horsewell, A.; Jiang, J.Z.; Zhou, Y.H. Second amorphous-to-crystalline phase transformation in Cu60Ti20Zr20 bulk